Sen. Richard Burr, R-N.C., listens to testimony before the Senate Committee for Health, Education, Labor, and Pensions hearing, Tuesday, May 12, 2020 on Capitol Hill in Washington. (Toni L. Sandys/The Washington Post via AP, Pool)
.By Mary Clare Jalonick and Eric Tucker
Sen. Richard Burr, R-N.C., stepped aside as chairman of the Senate Intelligence Committee on Thursday after the FBI served a search warrant for his phone as part of an ongoing insider-trading investigation tied to the coronavirus pandemic.
Senate Majority Leader Mitch McConnell announced the move, saying he and Burr had agreed it was in the Senate's best interests.
FBI officials showed up at Burr's home with the warrant on Wednesday, marking a significant escalation into the Justice Department's investigation into whether Burr broke the law with a well-timed sale of stocks before the coronavirus caused markets to plummet,
The Justice Department declined to comment. His attorney did not respond to phone and email messages, but said last month that the law is clear that any senator can participate in stock market trading based on public information "as Sen. Burr did."
Manhattan District Attorney Alvin Bragg filed a federal lawsuit against Rep. Jim Jordan on Tuesday, accusing the Republican of a “transparent campaign to intimidate and attack” him over his prosecution of former President Donald Trump.
Nashville’s governing council voted Monday to send Justin Jones straight back to the Legislature four days after he was expelled for his role in a protest on the state House floor.
The Justice Department is calling a Texas court ruling that would halt approval of the most commonly used method of abortion in the U.S. "extraordinary and unprecedented."
Nashville city councilors will likely appoint Justin Jones to his former seat on Monday while Memphis-area county commissioners will soon announce when they'll meet to fill the vacancy left by the expulsion of Justin Pearson, which Pearson himself is eligible to fill.
Health and Human Services Secretary Xavier Becerra said "Everything is on the table" when asked if he'd recommend that the FDA ignore Friday's ruling to reverse the agency's nearly 23-year-old approval of the medication abortion drug mifepristone.
